METHOD FOR ANCHORING OLIGONUCLEOTIDES TO A SUBSTRATE

Abstract: A method for anchoring oligonucleotides containing multiple reaction sites to a substrate. The substrate can be glass, inorganic or organic polymer, and metal. The reactive group of the substrate can contain electrophilic C=C double bonds for a nucleophilic addition, or disulfide for disulfide exchange. The multiple reactive groups contained on the oligonucleotide primer can be, for example, aminoalkyl, sulfhydryl, and thiophosphate groups. The oligonucleotide primer may take the configuration of a hairpin having a loop containing multiple reactive sites. In particular, a method for attaching an oligonucleotide primer to a glass substrate is disclosed that comprises preparing a bromoacetamide derivatized silane glass surface on a glass substrate, and reacting the bromoacetamide derivatized silane glass surface with an oligonucleotide primer containing multiple thiophosphate groups to bind the oligonucleotide primer to the glass substrate. An oligonucleotide containing multiple reactive sites, as well as a probe and a kit containing the same are also disclosed.

Description: METHOD FOR ANCHORING OLIGONUCLEOTIDES TO A SUBSTRATE The instant disclosure pertains to a method for anchoring oligonucleotides containing multiple reaction sites to a substrate. In particular, the instant disclosure pertains to a method for anchoring a hairpin-shaped oligonucleotide containing a multiple site thiophosphate backbone to a glass substrate. The instant disclosure also pertains to such an oligonucleotide, as well as a probe and a kit containing the same. BACKGROUND OF THE INVENTION Immobilization of probe or target molecules to a solid substrate is an integral part of many bio-assay techniques. Glass substrates are generally preferred over polymer substrates for a variety of reasons. Glass substrates possess increased tolerance to higher temperatures and higher ionic strength washes. Unlike polymer substrates which are porous, nonporous glass substrates retain less extraneous material which could contribute to background signals. Furthermore, because glass is non-porous, volumes of biomolecules spotted onto the surface of a glass substrate can be kept to a minimum. Glass has low background fluorescence which does not interfere appreciably with the sensitivity of fluorescence-based detection methods. Also, the silanol surface of glass can be readily modified by the silanization of functional silanes. In certain applications, it is preferable to covalently attach oligonucleotides and DNA samples to glass surfaces. Many of the methods presently used for covalently attaching oligonucleotides to glass surfaces employ bifunctional linkers or biotin-streptavidin linkages. For example, in Hybridization of DNA Targets to Glass-Tethered Oligonucleotide Probes. 4 MOLECULAR BIOTECHNOLOGY 213 (1995), Wanda G. Beattie et al. disclose the attachment of surface oligonucleotides by linking a 5' terminal amine to an epoxysilanized glass. The attachment reaction takes place in 100 mM NaOH, preferably. Small volumes (>lnL) of reaction solution are dispensed or "spotted" onto the substrate surface and evaporate very quickly. Because the dispensed liquid evaporates so quickly, chemical reactions must be fast and efficient in order that a sufficient number of molecules attach within a brief time period. Furthermore, the alkali concentration of the reaction solution increases as the solvent evaporates, causing oligonucleotide degradation, which in turn contributes to false signals and high background in the assay. Elevated alkali concentration may also cause the silane to detach from the glass substrate. Michael Pirrung and coworkers at Duke University have discovered that oligonucleotides with a 5'-phosphothioate react with bromoacetamide derivatized silane on a glass surface through nucleophilic substitution. The reaction takes approximately one half hour and is performed at neutral pH in aqueous solution. Unfortunately, 5'-phosphorylation is expensive, particularly for large numbers of oligomers, and any unsuccessful incorporation followed by sulfurization is not effective for attachment. Simply increasing the concentration of probes or DNA primers to enhance the reaction rate of attachment cannot solve the dilemma of attaching oligonucleotides to surfaces. For example, the surface area of a slide is limited. The highest density of oligonucleotides on a glass surface is 0.1 pmole/mm which is equivalent to one molecule every 39 square angstroms (Southern, et al., Nature Genetics Supplement, 21, 5-9 (1999)). The accessibility of oligonucleotides to the surface area (0.013 mm , 0.57 nL) of a dispensed drop in 130 μm diameter is saturated at 2.3 μM (1.33 fmole). Moreover, it is questionable whether densely packed substrates provide a solution, as densely packed substrates have been observed to reduce enzyme accessibility. As the above discussion suggests, improvements are still possible and desirable in the area of covalent linking of oligonucleotides to surfaces, especially glass surfaces. For example, a method is needed for covalently linking oligonucleotides to glass surfaces which exhibits improved reliability and reproducibility. In particular, a method is needed which allows better control of reaction efficiency, molecular density and conformation, and enzyme compatibility. Ideally, such a method would also be economical to use. These and other concerns are addressed in greater detail below. BRIEF SUMMARY OF THE INVENTION The instant disclosure pertains to a method for attaching an oligonucleotide primer to a substrate that comprises attaching a reactive group onto a substrate, and reacting the substrate with an oligonucleotide primer containing multiple reactive groups corresponding to the reactive group contained on the substrate to bind the oligonucleotide primer to the glass substrate. The substrate can be glass, inorganic or organic polymer, and metal. The reactive group of the substrate can contain electrophilic C=C double bonds for a nucleophilic addition, or disulfide for disulfϊde exchange. For example, the reactive group of the substrate can be maleimide and vinylsulfonate, benzene sulfonate, methanesulfonate, and trifluoromethanesulfonate . The multiple reactive groups contained on the oligonucleotide primer can be aminoalkyl, sulfhydryl, and thiophosphate groups. The oligonucleotide primer can contain multiple reactive groups that are the same, or it can contain at least two different reactive groups. The reactive groups contained on the oligonucleotide primer can be adjacent one another or distributed randomly throughout the primer. The oligonucleotide primer may also contain a nucleotide sequence corresponding to a protein binding site. The oligonucleotide primer may be in the configuration of a hairpin having a loop containing multiple reactive sites. In particular, a method for attaching an oligonucleotide primer to a glass substrate is disclosed that comprises preparing a bromoacetamide derivatized silane glass surface on a glass substrate, and reacting the bromoacetamide derivatized silane glass surface with an oligonucleotide primer containing multiple thiophosphate groups to bind the oligonucleotide primer to the glass substrate. The instant disclosure also pertains to an oligonucleotide primer comprising a backbone having multiple reactive groups for attaching said oligonucleotide primer to a substrate. The instant disclosure also pertains to an oligonucleotide primer bound to a substrate according to the method described above. The instant disclosure also pertains to a bioassay kit comprising an oligonucleotide primer bound to a substrate as described above. The instant disclosure also pertains to a method for immobilizing a PCR product to a substrate that comprises creating an oligonucleotide primer by phosphorylating the 5" end of the oligonucleotide primer having multiple reaction sites and modifying the '3 end of said oligonucleotide primer to include the PCR primer sequence, hybridizing the single-stranded 3 ' end of said oligonucleotide primer with the PCR product, and subjecting reaction product to enzymatic or chemical ligation. BRIEF DESCRIPTION OF THE DRAWINGS FIGURE 1 shows one possible reaction scheme for preparing a bromoacetamide derivatized silane glass surface. FIGURE 2a shows one embodiment of the oligonucleotide primer as a tail structure having 5 groups capable of reacting with the surface of the substrate. FIGURE 2b shows one embodiment of the oligonucleotide primer having a closed loop structure. FIGURE 2c shows one embodiment of the oligonucleotide primer as a hairpin molecule containing six nucleosides connected by thiophosphates in the loop and having a single-stranded 3' end and a 5' end in the double-stranded stem. FIGURE 2d shows a detailed view of the oligonucleotide primer depicted in FIGURE 2c. FIGURE 3 shows the attachment reaction between the oligonucleotide primer depicted in Figure 2 with the bromoacetamide derivatized silane glass surface shown in Figure 1. FIGURE 4 shows one embodiment of an arrayed primer extension reaction involving the instant oligonucleotides. FIGURE 5 shows one embodiment of a ligation reaction involving the instant oligonucleotides. FIGURE 6 shows the image of dye terminator labeled spots of both linear and hairpin oligonucleotide primer extension reactions conducted in Example 1 FIGURE 7A shows the image of dye terminator labeled spots of the primer extension of the ligation product of Example 2a. FIGURE 7B shows the image of dye terminator labeled spots of the primer extension of the ligation product of Example 2b. FIGURE 8A shows a comparison of an oligonucleotide having one reactive site (Peak a) with an oligonucleotide having five reactive sites (Peak b). As shown by the intensity of the label, Peak b has approximately 5 times the incorporated fluorescence label than Peak a which has only one reactive site. FIGURE 8B shows that an oligonucleotide having five reactive sites near the tail position (Peak a) has approximately the same incorporated fluorescence label as a haiφin oligonucleotide having five reactive sites (Peak b). DETAILED DESCRIPTION OF THE INVENTION The instant disclosure pertains to a method for anchoring oligonucleotides containing multiple reaction sites to a substrate. The substrate may be selected from a variety of materials, including glass, inorganic or organic polymer, and metal. Preferably, the substrate is glass. Although any type of glass may be used as a substrate, the preferred substrate is borosilicate glass. The substrate may take various physical forms, such as (but not limited to) slides or beads. The surface of the substrate is modified to facilitate attachment of the oligonucleotide to the surface. The oligonucleotide is generally modified with a nucleophile, such as aminoalkyl, sulfhydryl and thiophosphate groups. The surface of the solid support is modified with a corresponding reactive group, such as substituted benzenesulfonate, methanesulfonate, and trifluoromethanesulfonate as leaving groups for the nucleophile on the primer. The reactive groups on the solid support can also be maleimide, vinylsulfonate and acrylate as electrophilic C=C double bonds for a nucleophile, and disulfide modification for disulfide exchange. The oligonucleotide can also be modified with biotin and the surface of the substrate coated with streptavidin or avidin. Preferred reactive groups for the oligonucleotide include thiophosphate, aminoalkyl and sulfhydryl. Most preferably, the reactive groups are thiophosphate. Multiple reactive groups on the oligonucleotide have been found to enhance reaction efficiency. Preferably, the subject oligonucleotides contain multiple groups in a single molecule capable of reacting with the surface of the substrate. In general, the oligonucleotide can contain any number of reactive groups. Preferably, the oligonucleotide contains from one to five reactive groups (see Figure 2a which shows 5 reactive groups). The reactive groups may be arranged within one nucleoside of one another, or spaced throughout the oligonucleotide. Preferably, the reactive groups are arranged within two to six nucleosides of one another to create a hairpin structure in the oligonucleotide. The reactive groups may be the same or different. Although the subject oligonucleotides are not limited to those oligonucleotides having haiφin configurations; oligonucleotides having hair pin configurations such as those depicted in Figures 2c and 2d are preferred. Alternatively, the subject oligonucleotide may form a closed loop structure as shown in Figure 2b. In a preferred embodiment, the glass substrate contains a bromoacetamide derivatized silane glass surface. Figure 1 depicts one possible reaction scheme for preparing a bromoacetamide derivatized silane glass surface. The reactive slides can be prepared by starting from either regular glass slides or amine coated slides (commercially available from Amersham Pharmacia Biotech Inc and Corning Inc). The two-phase reaction is very efficient. One preferred embodiment of the oligonucleotide is shown in Figure 2c, and in greater detail in Figure 2d. In Figures 2c and 2d, the oligonucleotide primer is a haiφin molecule containing six nucleosides in the loop. The nucleosides in the loop are connected by thiophosphates. The haiφin has a single-stranded 3' end and a 5' end in the double-stranded stem. The single-stranded tail is equivalent to a single-stranded oligonucleotide. This approach allows fast and efficient attachment by maintaining relatively low concentrations of oligonucleotide primers and high concentrations of reactive groups. Attachment of the primer to the bromoacetamide derivatized silane glass surface is shown in Figure 3. Because the oligonucleotide can attach to the substrate at any one of the reactive sites in the loop, the reaction probability (reaction rate and efficiency) increases with the number of reactive sites contained in the loop. In addition, as the anchorage of the oligonucleotide is in the backbone, both 5' and 3' ends are free for modifications with reporter groups. This is more versatile than when the anchors are at either 5' or 3' end. While a reaction occurs at one end, the other end is available for further labeling. Moreover, the haiφin structure has a stem-loop moiety, which adds extra parameters to space the oligonucleotides from each other and control the density and desired upward conformation of the single-stranded moiety for primer extension as well as ligation. This attachment scheme offers significant advantages for immobilization of cDNA or any PCR product to microchips by hybridization and ligation. For example, if the 5' end of the haiφin is phosphorylated chemically during synthesis and the 3' single-stranded tail has a sequence which is complementary to a PCR primer sequence, the PCR product could hybridize with the single-stranded tail and be linked covalently by enzymatic or chemical ligation. Many of the current approaches for covalently attaching a PCR product to a surface focus mainly on modifying PCR primers. One disadvantage of this approach is that the reactive position may be buried in the self- folded macromolecule. The approach of hybridization followed by ligation may have a higher reaction probability than the simple interaction of reactive groups, since such bimolecular reaction depends on more factors than the sole collision probability of two substrates. The instant method and oligonucleotides are not limited to the hybridization of nucleic acids. For example, the oligonucleotide primer may also contain a nucleotide sequence corresponding to a protein binding site and would be useful, for example, in protein assays. The instant attachment method has the potential to immobilize oligonucleotides and DNAs by a covalent bond to a silica based glass surface with improved control of reaction efficiency, molecular density and conformation, and enzyme compatibility. Given the versatility of the instant oligonucleotides, it is possible that uses may be found with substrates other than those mentioned. The following examples are for illustration puφoses only and should not be used in any way to limit the appended claims. Examples Slide Preparation Pre-washed glass slides (25x75 mm microscope slides from VWR Scientific Products West Chester, PA) were immersed for 3 minutes in 95% ethanol (350 mL) containing approximately 2-3% wt/vol) 3-aminopropylmethylethoxysilane, pH 5.0, washed with ethanol, and cured in an oven at 75 °C for 4 hours. After curing, the glass slides were placed on a glass rack and immersed in 160 mL of N, N-dimethylformamide (DMF) containing bromoacetic acid (2.0 g, 14.9 mmol), 4-(dimethylamino)-pyridine (DMAP) (0.4 g, 3.3 mmol), and 1,3- dicyclohexylcarbodiimide (DCC) (4.0 g, 19.4 mmol). The reaction container was placed on a shaker in the dark for 4 hours. The slides were then washed with ethanol and air-dried. The haiφin oligonucleotide has five thiophosphates in the six nucleoside loop with a stem of five base pairs and a single stranded arm of seventeen bases which is commercially available from Genosys (The Woodland ,Texas). The thiophosphates are located to the right of lower case a's in the sequence of CCTGGaaaaaACCAGGGTATTCTTATAACTGAC. The haiφin oligonucleotide was dissolved and stored in l xTE (10 mM Tris HCl. 1 mM EDTA. pH 7.0). The concentration of oligonucleotide was calculated based on spectrophotometric measurement. The oligonucleotide (100 to 0.4 μM in a dilution series) was spotted on a bromoacetamide silane coated glass surface using a Molecular Dynamics Gen III spotter (Molecular Dynamics, Sunnyvale, CA). The volume of the spots was 0.7 nL and the size was 130 μm in diameter. Example 1 : Primer extension Example la The slide with primers was placed on a hot plate heated to 48 °C. Primer extension was carried out in 45 μL of Thermo Sequenase buffer (25 mM TAPS buffer, pH 9.3. 50 mM KC1. 2 mM MgCl , ImM 2-mercaptoethanol) with 0.5 μM of dye terminator Cy5-ddGTP, Thermo Sequenase DNA polym erase (4 unit). The templates used were 2 pmol of either a 23-mer CTGATCGTCAGTTATAAGAATAC, or a 28-mer CTGATCGTCAGTTATAAGAATACTAGCA (giving a branched structure at 5 'end of the haiφin stem). The reaction mixture was washed away with boiling water after being incubated for 10 minutes. The image of the dye terminator labeled spots was obtained using a Avalanche microscanner (Molecular Dynamics, Sunnyvale, CA). As shown in Figure 6, the integral of the fluorescence intensity of each spot was observed to vary linearly with the concentration of the spotted solution. Example lb Four oligonucleotides modified differently with thiophosphates in the backbone were purchased from Operon Technologies, Inc (Alameda, CA). The thiophosphates are located to the right of lower case a ' s in the following sequences: CCTGGaaACCAGGGTATTCTTATAACTGAC has two thiophosphates in the haipin-loop. aaaaaACCAGGGTATTCTTATAACTGAC has five thiophosphates in the 5' tail. AAaCCAGGGTATTCTTATAACTGAC and aAACCAGGGTATTCTTATAACTGAC. The oligonucleotide was dissolved and stored in l TE buffer. The concentration of oligonucleotide was calculated based on spectrophotometric measurement. The primers were spotted from 50 μM solution. Primer extension was carried out similarly in 45 μL of Thermo Sequenase buffer. The templates used were 2 pmol of the 23-mer CTGATCGTCAGTTATAAGAATAC. The signal intensity of the incoφorated Cy5-ddGTP changed dramatically with the number of thiophosphates in the primers. As shown in Figures 8A, the signal had a five fold difference in the primers with either one (Peak a) or five thiophosphates (Peak b). Figure 8B shows that an oligonucleotide having five reactive sites near the tail position (Peak a) has approximately the same incorporated fluorescence label as a haiφin oligonucleotide having five reactive sites. Example 2: Ligation Example 2a A 50-mer thiophosphate haiφin, pGAATTCTACCCTGGaaaaaaCCAGGGTAGAATTCGTAAAACGACGGCCAG. was phosphorylated chemically during synthesis and immobilized to a glass surface as described previously. The ligation is performed in 40 μL of enzyme buffer (66 mM Tris-HCl, pH 7.6, 6.6 mM MgCl 2 , 10 mM DTT, 66 μM ATP) containing 3 units of T4 DNA ligase and 200 pmol of a ligation fragment, 3'-CATTTTGCTGCCGGTCACGGTTC-5'. The reaction was incubated at room temperature for 2 hours and washed with hot water. A primer extension was then performed with Cy5-ddTTP. The ligation product served as a self-extension primer to be labeled with Cy5-ddTTP by thermal sequenase. See Figure 7a. Example 2b: The ligation of a 100-mer PCR product of pUC- 18 was performed with thermal stable Pfu DNA ligase at 48 °C. The reaction mixture contained 40 μL of enzyme buffer (20 mM Tris-HCl, pH 7.5, 20 mM KCl, 10 mM MgCl 2 , 1 mM DTT, 10 μM ATP, 0.1% Igepal) and 4 units of Pfu DNA ligase and a 100-mer fragment (5 pmole) of pUC-18, which was amplified by universal and reverse Ml 3 primers. The reaction was incubated at 48 °C for 15 min and then washed with sufficient hot water to remove excess reaction components. A primer extension was then performed with Cy3-ddTTP. The ligation product serves as a self-extension primer to be labeled with Cy3-ddTTP by thermal sequenase to confirm the ligation. See Figure 7b. Although various embodiments of the instant invention are described in detail above, the instant invention is not limited to such specific examples. Various modifications will be readily apparent to one of ordinary skill in the art and fall within the spirit and scope of the following appended claims.

Claims: CLAIMS What is claimed is: 1. A method for attaching an oligonucleotide primer to a substrate that comprises: A. attaching a reactive group onto a substrate, and B. reacting an oligonucleotide primer containing multiple reactive groups corresponding to the reactive group contained on the substrate with the substrate of A) to bind the oligonucleotide primer to the glass substrate. 2. The method according to Claim 1, wherein the reactive group of the substrate of A) contains electrophilic C=C double bonds for a nucleophilic addition. 3. The method according to Claim 1, wherein the reactive group of the substrate of A) contains disulfide for disulfide exchange. 4. The method according to Claim 1 , wherein the reactive group of the substrate of A) is selected from the group consisting of maleimide and vinylsulfonate. 5. The method according to Claim 1, wherein the reactive group contained on the substrate of A) is selected from the group consisting of benzene sulfonate, methanesulfonate, and trifluoromethanesulfonate. 6. The method according to Claim 1, wherein the substrate is selected from the group consisting of glass, polymer, and metal. 7. The method according to Claim 1, wherein the substrate is glass. 8. The method according to Claim 1, wherein the substrate is inorganic or organic polymer. 9. The method according to Claim 1 , wherein the multiple reactive groups contained on the oligonucleotide primer are selected from the group consisting of aminoalkyl, sulfhydryl, and thiophosphate groups. 10. The method according to Claim 1, wherein the multiple reactive groups are the same. 11. The method according to Claim 1 , wherein the oligonucleotide primer contains at least two different reactive groups. 12. The method according to Claim 1, wherein the multiple reactive groups contained on the oligonucleotide primer are adjacent one another. 13. The method according to Claim 1, wherein the multiple reactive groups contained on the oligonucleotide primer are distributed randomly throughout the primer. 14. The method according to Claim 1, wherein the oligonucleotide primer contains a nucleotide sequence corresponding to a protein binding site. 15. A method for attaching an oligonucleotide primer to a glass substrate that comprises: A. preparing a bromoacetamide derivatized silane glass surface on a glass substrate, and B. reacting an oligonucleotide primer containing multiple thiophosphate groups with the bromoacetamide derivatized silane glass surface of A) to bind the oligonucleotide primer to the glass substrate. 16. An oligonucleotide primer comprising a backbone having multiple reactive groups for attaching said oligonucleotide primer to a substrate. 17. The oligonucleotide primer according to Claim 16 further comprising both a 5' end and a 3' end available for modification. 18. The oligonucleotide primer according to Claim 16 wherein the primer is modified with a nucleophilic group. 19. The oligonucleotide primer according to Claim 16 wherein the multiple reactive groups are selected from the group consisting of aminoalkyl, sulfhydryl, and thiophosphate groups. 20. The oligonucleotide primer according to Claim 16, wherein the reactive groups are thiophosphate groups. 21. The oligonucleotide primer according to Claim 16, wherein the multiple reactive groups are the same. 22. The oligonucleotide primer according to Claim 16, wherein the oligonucleotide primer contains at least two different reactive groups. 23. The oligonucleotide primer according to Claim 16, wherein the reactive groups are located randomly throughout the oligonucleotide primer. 24. The oligonucleotide primer according to Claim 16, wherein the multiple reactive groups contained on the oligonucleotide primer are adjacent one another. 25. The oligonucleotide primer according to Claim 16, wherein the primer is in the configuration of a haiφin having a loop containing reactive sites. 26. The oligonucleotide primer according to Claim 25, wherein the loop is open. 27. The oligonucleotide primer according to Claim 25, wherein the loop is closed. 28. The oligonucleotide primer according to Claim 16, further comprising a nucleotide sequence corresponding to a protein binding site. 29. An oligonucleotide primer bound to a substrate according to the method of Claim 1. 30. A bioassay kit comprising an oligonucleotide primer bound to a substrate according to the method of Claim 1. 31. The bioassay kit according to Claim 30, wherein the substrate is in the form of a bead. 32. The bioassay kit according to Claim 30, wherein the substrate is in the form of a planar slide. 33. A bioassay kit comprising the oligonucleotide primer of Claim 16. 34. A method for immobilizing a PCR product to a substrate that comprises: A. creating an oligonucleotide primer by phosphorylating the 5' end of the oligonucleotide primer according to Claim 2, and modifying the '3 end of said oligonucleotide primer to include the PCR primer sequence, B. hybridizing the single-stranded 3 ' end of said oligonucleotide primer with the PCR product, and C. subjecting reaction product of B) to enzymatic or chemical ligation.

Inventors: ZHAO XIAODONG, ZHAO, XIAODONG
Applicants: AMERSHAM PHARM BIOTECH INC, AMERSHAM PHARMACIA BIOTECH, INC.
Application year: 2000
Main classification: C07H21
IPC codes: C07B61, C07H21